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Introduction
Cell differentiation is an intrinsically complex process that is 
regulated  by  diverse  transcriptional  pathways  and  epigenetic 
modifications.1-6 These signaling pathways stimulate coordinated 
changes in the expression of hundreds of genes in precise response 
to specific environmental signals. Because of the critical impor-
tance of cell differentiation to organism and tissue development 
and to cellular specialization, abnormal differentiation is directly 
linked to many human diseases, including cancer, neurodegen-
erative diseases, inflammatory diseases, viral infections and heart 
diseases.1-6
Interestingly, abnormal glutathione (GSH) homeostasis has 
also been reported in these same disease states, although there 
is as yet no direct link between the changes in GSH levels and 
either the altered cell differentiation or the etiology of these dis-
eases.7,8 Because GSH is involved in a multitude of biochemical 
pathways and cellular processes, changes in GSH levels simulta-
neously impact all of these processes, and thus it has been difficult 
to establish cause and effect relationships.8 Nevertheless, there is 
now growing evidence that reactive oxygen species function as 
intracellular messengers for cell growth and differentiation,9-19 
and that GSH levels and thiol redox state modulate both reac-
tive species availability, and cell growth and differentiation,20-43 
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although the specific mechanisms and pathways involved remain 
largely undefined. There are many redox sensitive transcription 
factors, including Nrf2, AP-1, c-Jun, Bach1, NFκB, IKKβ sub-
unit, interferon regulatory factor 3, p53 and Pax-8,8 and each of 
these may contribute to the effects of the reactive oxygen species 
on cell differentiation. In particular, there is now growing evi-
dence that Keap1-Nrf2 activation can alter differentiation out-
come; however, the effects vary from stimulation to inhibition of 
differentiation depending on the cell type and the chemical prop-
erties and dose of the stimulus used to modulate Nrf2.27,39,40,44-54
Previous studies that have examined the role of GSH on cell 
differentiation have shown that extreme and sustained GSH deple-
tion prior to the induction of differentiation markedly impairs the 
process.23-28 However, it is important to consider both the extent 
and timing of depletion when making conclusions concerning 
the effects of GSH on differentiation. In order to better under-
stand the significance of GSH homeostasis during differentia-
tion, the present study measured intracellular GSH levels during 
the differentiation process, as well as the effects of a more moder-
ate GSH depletion on the differentiation process. In addition, to 
distinguish the temporal sequence of events, GSH depletion was 
initiated several hours after the addition of the differentiation-
inducing stimulus. The studies were performed in HL-60 cells, a 
cell line originally isolated from an acute promyelocytic leukemia 
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exploited to identify the common characteristics as well as the 
unique mechanisms involved in neutrophilic, monocytic, and 
eosinphilic maturation. Additionally, HL-60 cells retain the abil-
ity to spontaneously differentiate in culture (maturation in the 
absence of a differentiation inducer).55 This feature can be utilized 
experimentally to identify factors that are capable of enhancing 
or preventing normal terminal differentiation.
The present results demonstrate that GSH levels are dynamic 
during HL-60 differentiation, and that treatment with relatively 
low  concentrations  of  1-chloro-2,4-dinitrobenzene  (CDNB) 
and diethylmaleate (DEM) results in enhanced differentiation. 
Taken together, these finding provide additional evidence that 
intracellular GSH levels play a role in determining differentia-
tion outcomes, and that it may thus contribute to conditions and 
disease states characterized by abnormal differentiation.
Results
There is a small, transient increase in intracellular GSH levels 
during both granulocytic and monocytic terminal HL-60 cell 
differentiation.  To  examine  whether  intracellular  GSH  levels 
change during terminal cell differentiation, HL-60 cells were 
treated with DMSO, a granulocytic differentiation inducer, and 
GSH and GSSG levels were measured at various time points 
(Fig. 1). Glutathione levels remained relatively constant in con-
trol cells; however, the levels in DMSO-treated HL-60 cells were 
slightly higher at the 1-day time point (Fig. 1A). There was no 
measurable change in the percent of GSSG or reduced GSH   
(Fig. 1C), suggesting that the transient increase in GSH is due to 
an increase in total glutathione and not GSH or GSSG alone.
Because DMSO induces HL-60 cells to mature into neutro-
phils, it was important to examine whether this transient increase 
in GSH was specific for this pathway. To test this possibility, 
cells were treated with 500 nM VD3, which induces matura-
tion into monocyte-like cells, and were collected at various times 
for analysis of total glutathione levels (Fig. 1B). As expected,   
glutathione levels remained relatively constant in control cells.   
In VD3-treated cells, glutathione levels were slightly higher at 9 h 
after VD3 exposure (Fig. 1B), but were comparable to controls 
at the other time points. As with the DMSO-treated cells, there 
was no change in the percent of GSSG or GSH (Fig. 1D) at the 
time points tested. Taken together these data suggest that a small 
transient increase in GSH is a feature of HL-60 maturation.
The transient increase in glutathione precedes changes in 
CD11b  expression  and  cell  cycle  distribution,  but  coincides 
with an increase in NBT reduction capacity. To elucidate the 
timing of this transient increase in glutathione in relation to 
differentiation marker expression, differentiation markers were 
assessed following DMSO and VD3 exposure. Because, cells that 
have differentiated exit the cell cycle, one way to identify the time 
when HL-60 cells are beginning to differentiate is to look at a 
time course of cell cycle distribution after treatment with dif-
ferentiation inducers. A decrease in S-phase (Fig. 2A and B) and 
an increase in G1-phase cells (data not shown) occurred 48 hours 
after exposure to DMSO or VD3. There were no differences in 
cell cycle distribution between cells induced to differentiate and 
patient,55 which are a well-characterized model for studying ter-
minal differentiation events. HL-60 cells can mature into neu-
trophils upon exposure to dimethyl sulfoxide (DMSO)56,57 or 
all-trans-retinoic acid (ATRA),58 or to monocytes upon exposure 
to 1α,25-dihydroxyvitamin D3 (VD3).59 This feature has been 
Figure 1. A transient increase in glutathione occurs during DMSO, and 
VD3-induced Hl-60 differentiation. Total glutathione content (nano-
moles/mg protein) in control cells, and those treated with 1.5% DMSO 
at 0, 1, 2, 3, 4 and 5 days of culture (A), or with 500 nM VD3 cells at 0, 
9, 16, 24 and 48 hours of culture (B). Reduced glutathione (% of total 
glutathione) was determined for control, DMSO (C), and VD3-treated 
HL-60 cells (D). Samples were assayed in triplicate, and data are rep-
resented as mean ± S.E. of five to six experiments (A and B), and three 
experiments (C and D). Statistical significance is expressed as *p < 0.05 
versus control values.
Figure 2. The transient increase in glutathione precedes changes 
in S-phase cell cycle distribution and CD11b expression. S-phase cell 
cycle distribution was assessed after 0, 1, 2, 3, 4 and 5 days of DMSO 
exposure (A), and 0, 9, 16, 24 and 48 hours of VD3 exposure (B). Total 
CD11b cell surface marker expression was measured in HL-60 cells af-
ter 0, 1, 2, 3, 4 and 5 days of 1.5% DMSO exposure (C), and 0, 9, 24 and 
48 hours of 500 nM VD3 treatment (D). Data are represented as mean 
± S.E. of three to four experiments. Statistical significance is expressed 
as *p < 0.05 versus control values.www.landesbioscience.com  Oxidative Medicine and cellular Longevity  55
under these conditions.61 Because the goal of these studies was 
to rapidly deplete cellular GSH levels, it was not possible to use 
the GSH synthesis inhibitor L-buthionine sulfoximine (BSO), 
which depletes GSH levels relatively slowly.
At  approximately  3  hours  after  incubation  with  0.5  mM 
DEM, intracellular GSH levels were approximately 40% of con-
trols in both uninduced and VD3-treated cells (Fig. 5A and C).   
At  6  hours  after  DEM  incubation,  GSH  returned  to  control   
levels, and 20 hours later it was higher in DEM-treated samples 
(Fig. 5A and C). This increase in GSH levels 20 hours after DEM 
treatment suggests that GSH is upregulated in response to the 
depletion that occurred earlier. Similar results were observed in 
cells treated with 5 μM CDNB, although no significant increase 
in  glutathione  occurred  after  20  hours  of  CDNB  treatment   
controls at the 1-day, and 9-hour time points, where the increase 
in GSH was observed.
As HL-60 cells mature, changes in cell surface marker expres-
sion occur, including increases in CD11b and decreases in CD71. 
An increase in CD11b marker expression occurred 2 days and 
24 hours after DMSO and VD3 exposure, respectively (Fig. 2C 
and D). A decrease in CD71 expression also occurred 24 hours 
after VD3 treatment (data not shown). In DMSO-treated cells 
there was a decrease in CD71 expression at 1 day after exposure, 
followed by a dramatic decrease 2 days after exposure (data not 
shown). These data reveal that the transient increase in intracel-
lular GSH precedes the shift in CD11b expression, but may coin-
cide with CD71 expression in the case of DMSO-induction.
As HL-60 cells differentiate, superoxide anion production, a 
result of upregulated NADPH oxidase activity, also increases,57,60 
and this was supported by the results 
of  the  NBT  assay  (Fig.  3).  An 
increase in NBT reduction capacity 
first became apparent at the 24-hour 
time point after DMSO treatment, 
but  was  not  statistically  different 
until the 48 h time point (Fig. 3A). 
There was an increase in NBT reduc-
tion activity in VD3-treated HL-60 
cells at the 9 h time point (Fig. 3B), 
suggesting that there is an increase in 
NADPH oxidase activity that occurs 
roughly  at  the  same  time  as  the 
increase in intracellular glutathione 
levels, and that continues to increase 
with time. One possible interpreta-
tion  for  these  observations  is  that 
the initial increase in NADPH oxi-
dase-produced  reactive  intermedi-
ates stimulates increased production 
and/or  retention  of  cellular  GSH, 
and that GSH values then return to 
normal after accommodation to the 
progressive increase in NADPH oxi-
dase activity.
Treatment  with  GSH  depletors 
augments HL-60 cell differentiation 
marker expression. To further define the role of GSH in HL-60 
differentiation, cells were depleted of GSH and differentiation 
marker expression was assessed. To more selectively investigate 
the importance of the transient increase in GSH during early 
maturation, GSH depleting agents were added just prior to the 
anticipated transient increase. Cells were treated with relatively 
low levels of GSH-altering agents for a period of 3 h to create 
a moderate and transient depletion of GSH early in differentia-
tion (Fig. 4). The agents used to deplete GSH were 1-chloro-2,4-
dinitrobenzene (CDNB; 5 μM) and diethylmaleate (DEM; 0.5 
mM). Both of these compounds are excellent substrates for the 
glutathione S-transferases, allowing for a rapid GSH depletion, 
whereas the spontaneous (i.e., non-enzymatic) reaction of CDNB 
or DEM with GSH or other cellular thiols is comparatively slow 
Figure 3. NBT reduction capacity during DMSO and VD3-induced HL-
60 differentiation. NBT reduction capacity in hL-60 cells after 0, 8, 16, 
24 and 48 hours of DMSO exposure (A), and after 0, 6, 9 and 24 hours 
of VD3 treatment (B). Data are represented as mean ± S.E. of three 
experiments. Statistical significance is expressed as *p < 0.05 versus 
control values.
Figure 4. Experimental design of GSH depletion experiments during induced HL-60 cell differentia-
tion. HL-60 cells were incubated with GSH depleting agents, 0.5 mM DEM or 0.5 μM CDNB, either 
with or without 5 mM GSH. Treatment occurred during differentiation, after exposure to maturation 
agents, but before the transient increase in GSH observed after VD3 treatment. Cells were collected 
for GSH analysis 3, 6 and 20 hours after the initial incubation with GSH-altering agents. NBT reduction 
was analyzed at 24 hours, and cell cycle and cell surface marker expression 48 hours after exposure to 
differentiation inducers, 500 nM VD3 or 500 nM ATRA.56  Oxidative Medicine and Cellular Longevity  Volume 3 Issue 1
(Fig. 5B and D). The addition of 5 mM GSH to the culture 
medium modulated the effects of DEM and CDNB treatment 
at all time points. These effects of the exogenous GSH are likely 
explained both by the ability of this added GSH to react slowly 
with the DEM or CDNB in the culture medium, thus lowering 
the effective doses to the cells, and its ability to sustain intracel-
lular GSH levels under these experimental conditions (Fig. 5).
The effects of GSH depletion on cell surface marker expres-
sion were assessed in HL-60 cells treated with two different dif-
ferentiation inducers, VD3 and ATRA (Fig. 6). VD3-exposed 
cells treated with DEM or CDNB had higher CD11b expression 
and lower CD71 expression at 48 hours after treatment (Fig. 6A). 
Comparable trends were observed for ATRA-induced HL-60 cells 
upon treatment with GSH-depleting agents (Fig. 6B), indicating 
that moderate GSH depletion with DEM or CDNB enhances 
cell surface marker expression associated with the differentiated 
HL-60 phenotype. Note that GSH supplementation largely pre-
vented the effects of DEM and CDNB in VD3-treated cells (Fig. 
6A), but it had small effects in ATRA-treated cells (Fig. 6B). The 
reason for this is not known, but may be related to differences in 
the time frames of differentiation induced in cells treated with 
VD3 and ATRA (data not shown).
Analysis of S-phase cells was also performed at 48 hours after 
the initial exposure to VD3 or ATRA, and the results reveal 
that both DEM and CDNB treatment decreased the propor-
tion of VD3-exposed cells in S-phase (Fig. 6C). In line with the 
VD3 observations, ATRA-treated cells also exhibited decreased 
S-phase populations after DEM treatment (Fig. 6D); however, 
there was no significant change in S-phase distribution after 
CDNB incubation, and GSH supplementation appeared to have 
no effect on DEM and CDNB exposure (Fig. 6D). Because 
the ATRA-induced decrease in S-phase cell cycle population 
occurred later than VD3-induced alterations (data not shown), 
the  decreases  in  S-phase  population  that  is  associated  with 
ATRA-induced differentiation may be apparent at later time 
points. When a 3-hour incubation with DEM occurred 22 hours 
after VD3 induction, no enhancement of CD11b or decrease in 
CD71 expression took place (data not shown), suggesting that 
the effects of GSH on differentiation marker expression is time 
dependent. NBT reduction data also suggested that treatment 
with  GSH-depleting  agents  enhanced  HL-60  differentiation 
(Fig.  6).  Both  VD3-treated  and  ATRA-treated  HL-60  cells 
exposed to either DEM or CDNB had higher NBT reduction 
capacity when compared to controls (Fig. 6E and F).  Taken 
together, these results and the observations reported above are 
Figure 5. Total glutathione levels in control and VD3-induced HL-60 
cells after DEM, and CDNB treatment. Control cells were incubated 
with either 0.5 mM DEM (A) or 5 μM CDNB (B), in the presence or ab-
sence of 5 mM GSH for a 3 hour period. HL-60 cells were treated with 
500 nM VD3, and 4 hours later cells were incubated with either 0.5 mM 
DEM (C) or 5 μM CDNB (D) for 3 hours, in the presence or absence of 
5 mM GSH. Cells were collected 3, 6 and 20 hours after treatment with 
GSH-altering agents for analysis of total intracellular glutathione levels. 
Samples were analyzed in triplicate for each experiment. Data are 
represented as mean ± S.E. of three experiments. Statistical significance 
is expressed as *p < 0.05 versus control values.
Figure 6. DEM and CDNB altered differentiation marker expression 
in VD3, and ATRA-induced HL-60 cells. HL-60 cells were exposed to 
500 nM VD3 or 500 nM ATRA. Approximately 4 hours later cells were 
treated with either 0.5 mM DEM or 5 μM CDNB for 3 hours, in the 
presence or absence of 5 mM GSH. At 48 hours after differentiation 
induction, cells were collected for the analysis of CD11b and CD71 
expression (A and B), and S-phase populations (C and D). At 24 hours 
after VD3 exposure, or ATRA treatment cells were collected to assess 
NBT reduction capacity (E and F). Data are represented as mean ± S.E. 
of three to five experiments. Statistical significance is expressed as  
*p < 0.05 versus control values.www.landesbioscience.com  Oxidative Medicine and Cellular Longevity  57
differentiation inducer leads to reactive oxygen species produc-
tion, which in turn activate cell differentiation by an as yet unde-
fined mechanism, as well as compensatory responses to deal with 
these reactive moieties, including transiently elevated GSH levels 
(Fig. 1A and B). When GSH levels are transiently depleted, reac-
tive oxygen species availability is temporarily enhanced, leading 
to the activation of the cell differentiation program. Conversely, 
when thiol levels are augmented via the addition of NAC, reactive 
oxygen species are quenched, and as a result less oxidative signals 
are available to activate redox-sensitive differentiation pathways, 
and the cell differentiation program is impeded. On the other 
hand, under conditions of severe and sustained GSH depletion, 
excessive accumulation of reactive intermediates may cause inap-
propriate activation of signaling cascades or other cell injury, and 
thus thwart the normal cell differentiation program. Additional 
studies are needed to test this model, and to define the signaling 
pathways involved in these responses.
Although  some  previous  studies  have  examined  the  role 
of  GSH  concentrations  on  cell  differentiation,  these  studies 
have  examined  the  effects  of  relatively  drastic  and  sustained 
GSH depletion on this process, and most have depleted cellu-
lar GSH levels prior to or simultaneously with the induction of 
consistent with the hypothesis that a moderate, transient GSH 
depletion augments HL-60 differentiation.
NAC  supplementation  reduces  differentiation  marker 
expression  in  VD3-induced  HL-60  cells. If  trans i e n t  G S H  
depletion enhances HL-60 differentiation, then it was hypoth-
esized  that  thiol  supplementation  may  diminish  differentia-
tion. To investigate this, HL-60 cells were treated with NAC, a 
derivative of the amino acid L-cysteine, at 4 hours after VD3-
induction, and differentiation markers were assessed (Fig. 7). 
CD11b expression was lower and CD71 expression was higher 
in  NAC-treated  cells  (Fig.  7A).  In  addition,  NAC-treated 
cells also had decreased NBT reduction capacity (Fig.  7B). 
Although these data show that NAC treatment decreased dif-
ferentiation marker expression in VD3-treated HL-60 cells, it 
did so without increasing intracellular GSH levels (GSH levels 
were 74% ± 6%, and 68% ± 6%, of control values 6 hours after 
5 mM NAC, and 10 mM NAC, respectively), indicating that 
total thiol levels are likely the important determinants of these 
effects on differentiation.
GSH  depletion  enhances  spontaneous  HL-60  cell  differ-
entiation.  A  small  proportion  of  HL-60  cells  spontaneously 
differentiate in culture, and thus this feature can be exploited 
experimentally to test the effects of GSH depletion on spontane-
ous differentiation. In order to determine if lowering intracellular 
GSH changes spontaneous maturation, un-induced HL-60 cells 
were incubated with DEM or CDNB for 3 hours, and differen-
tiation markers were assessed at 3, 6 and 20 hours after the start 
of incubation. There was an increase in CD11b and a decrease in 
CD71 cell surface marker expression in both DEM and CDNB 
exposed cells (Fig. 8A). Control cells exposed to DEM or CDNB 
also exhibited increased NBT reduction capacity (Fig. 8B).
Discussion
There is increasing evidence that the balance between the produc-
tion of intracellular reactive oxygen species and the levels of GSH 
and other antioxidants modulates redox sensitive signaling path-
ways that regulate many cellular processes, including proliferation 
and differentiation; however, the precise mechanisms responsible 
for  these  complex  responses  and  interactions  remain  largely 
unknown.9-19 The present study examined intracellular GSH lev-
els during HL-60 cell differentiation, and the effects of two GSH 
depletors, CDNB and DEM, on the differentiation process. The 
results demonstrate that there is a small transient increase in total 
intracellular glutathione, but no apparent change in GSH/GSSG 
ratio, during both granulocytic and monocytic HL-60 matu-
ration.  This  increase  in  intracellular  glutathione  precedes  the 
changes in proliferation and CD11b cell surface marker expres-
sion, but coincides with an increase in NBT reduction capacity, a 
measure of superoxide anion production. In addition, treatment 
with low doses of CDNB and DEM to transiently decrease GSH 
levels augmented both induced and spontaneous differentiation, 
whereas NAC supplementation diminished it. Taken together 
with previous findings in other cell systems, the present data are 
consistent with a model in which reactive oxygen species act as 
signal mediators of cell differentiation. Thus, stimulation with a 
Figure 7. NAC treatment decreases differentiation marker expres-
sion in VD3-induced HL-60 cells. HL-60 cells were treated with NAC 
(5 or 10 mM) 4 hours after treatment with 500 nM VD3. Cell surface 
marker expression (A), and NBT reduction (B) were assessed 48, and 
24 hours after VD3 treatment, respectively (B). Samples were analyzed 
in triplicate for NBT experiments. Data are represented as mean ± S.E. 
of three experiments. Statistical significance is expressed as *p < 0.05 
versus control values.58  Oxidative Medicine and Cellular Longevity  Volume 3 Issue 1
In addition to enhancing differentiation marker expression in 
induced HL-60 cells, CDNB and DEM also augmented spon-
taneous cell differentiation. Thus, altering thiol abundance not 
only affects monocytic and granulocytic pathways upregulated 
by VD3 and ATRA, respectively, but also stimulates the mecha-
nisms responsible for spontaneous maturation. These findings 
further support the hypothesis that GSH levels are important 
determinants of differentiation events.
The present results also reveal that glutathione levels are regu-
lated in a complex fashion during maturation. A small transient 
increase in glutathione levels was observed during both granulo-
cytic and monocytic differentiation induction, suggesting that 
this may be a general feature of the differentiation process. Of 
significance, the measured increase in NBT reduction capacity 
coincided with the transient increase in GSH at 9 hours after 
VD3 exposure, and at 1 day after DMSO treatment, indicating 
a simultaneous increase in GSH and superoxide anion produc-
tion capacity. Because oxidative stimuli are known to increase 
the expression of the rate limiting enzyme in GSH synthesis and 
hence elevate GSH levels,43 the initial increase in superoxide anion 
may cause GSH levels to become transiently higher. Although 
this association provides a possible explanation for the transient 
increase, no causal relationship has yet been established. Despite 
the fact that the increase in superoxide anion production may be 
a contributing factor to the transient increase in GSH, another 
possibility exists. HL-60 cells do not differentiate as a synchro-
nous population, and thus there will always be some cells that are 
further along the differentiation pathway. As a result, some cells 
will attain the ability to produce superoxide anion earlier than 
others, and these data may be a reflection of this phenomenon.
Although these findings reveal a novel feature of HL-60 dif-
ferentiation, many details concerning the nature of this transient 
increase still remain unclear. No changes in the GSH/GSSG 
ratio were detected in the current studies, and thus the transient 
increase in GSH appears to be explained by an increase in the 
absolute levels of glutathione (proportional increases in both GSH 
and GSSG levels). An increase in the absolute level of glutathione 
will affect any cell process that is dependent on this tripeptide’s 
availability, including enzyme activity, transport activity, gluta-
thionylation, and cysteine availability. It is possible that higher 
glutathione levels may be required for some differentiation event, 
although additional studies are needed to test this possibility.
While these data do not support the hypothesis that a shift 
in intracellular thiol-redox status (a change in GSH/GSSG) is 
responsible for the transient increase in glutathione, this notion 
cannot be discounted. It is clear that thiol-redox status is not 
uniform throughout intracellular organelles, and differs within 
specific  cellular  compartments.63  If  variations  in  GSH/GSSG 
do exist within the cell, then localized shifts in the GSH/GSSG 
ratio may be playing a critical role in redox signaling events, and 
hence cell processes such as differentiation. Additional studies 
are needed to identify possible changes within specific cellular 
compartments.
If GSH levels are an important factor in general differentia-
tion events, then agents that alter its concentrations will affect 
differentiation  outcomes.  As  mentioned  earlier,  diseases  of 
differentiation.23-28 Not surprisingly, differentiation is impaired 
under these severe conditions. In contrast, the present findings 
demonstrate that a more moderate and transient GSH depletion 
that is applied during the maturation process leads to enhanced 
HL-60 cell differentiation. In particular, the results show that 
when HL-60 cells were treated with the GSH-depleting agents 
at a time point that coincided with the differentiation-associated 
increase in intracellular GSH, differentiation marker expression 
was enhanced.
Consistent with this model, NAC treatment diminished dif-
ferentiation marker expression, the opposite effect of GSH deple-
tion treatments; however, it did so without increasing GSH levels. 
Note that NAC itself is a potent antioxidant, and has been shown 
to inhibit transcription factors involved in GSH synthesis. NAC 
inhibits NF-E2-related factor-2 (Nrf2), and thus downregulates 
the transcription of γ-glutamylcysteine ligase, the rate-limiting 
enzyme in GSH synthesis.62,63 These observations suggest that 
the thiol groups of GSH or NAC are likely critical for altering 
differentiation outcomes.
Figure 8. DEM, and CDNB enhanced differentiation marker expres-
sion in un-induced hL-60 cells. hL-60 cells were treated with either 
0.5 mM DEM or 5 μM CDNB for 3 hours, in the presence or absence 
of 5 mM GSH. Cells were collected at 48 hours for CD11b and CD71 
expression (A), and at 24 hours for NBT reduction analysis (B). Samples 
were analyzed in triplicate for NBT experiments. Data are represented 
as mean ± S.E. of five to nine experiments. Statistical significance is 
expressed as *p < 0.05 versus control values.www.landesbioscience.com  Oxidative Medicine and cellular Longevity  59
Cell cycle analysis. Cells were aliquoted at 1 x 106 cells/ml, 
were fixed in a 75% ethanol solution, and were kept at 4°C prior 
to analysis. On the day of the assay, cells were resuspended in 
1 mg RNAse/ml phosphate buffered saline (PBS). After a 30 
min incubation at room temperature, cells were resuspended in   
20  μg  propidium  iodide  (PI)/ml  PBS,  and  analyzed  using  a 
Benton Dickson FACSCalibur flow cytometer (San Jose, CA).
CD11b and CD71 differentiation marker expression. Cells 
were aliquoted at 1 x 106 cells/ml, washed in PBS, and incubated 
with 15 μl of CD11b-PE and CD71-FITC (BD Biosciences, San 
Jose, CA) for 20 min at room temperature, in the dark. After a 
wash with PBS, supplemented with 1% FBS, cells were centri-
fuged for 7 min at 1,000 RPM. Cells were resuspended in 1 ml 
of PBS and kept at 4°C, until analyzed using a Benton Dickson 
FACSCalibur flow cytometer (San Jose, CA). Isotype controls for 
PE, and FITC fluorescence (BD Bioscience), as well as positive 
controls for CD11b-PE, and CD71-FITC, were run during each 
experiment.
Nitroblue tetrazolium (NBT) assay. Approximately 5 x 105 
cells were resuspended in 0.5 ml PBS containing NBT (200 nM) 
and phorbol 12-myristate 13-acetate (PMA) (500 nM), the acti-
vating agent. Cells were incubated at 37°C containing for 30 
minutes. Approximately 1N HCl was added to the samples to 
stop the reaction. The formazan precipitate was solubilized in 
DMSO  and  transferred  to  96-well  plates.  Absorbance  of  the   
precipitates was analyzed in a spectrophotometric plate reader at 
572 nm.
Statistical analysis. Statistical analysis was performed using 
Statview 5 (SAS Institute Inc., Cary, NC). Data were analyzed 
using  one-way  ANOVA  and  Fisher’s  PLSD  posthoc  analyses.   
In all cases p values of less than 0.05 were considered statistically 
significant.
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differentiation (e.g., cancer, autoimmune disease and aging) are 
also associated with abnormal GSH levels. Although at this point 
the relationship is only a correlative one, understanding how GSH 
affects cellular differentiation may provide important insight into 
the etiology or treatment of these conditions. These findings may 
also have implications for in utero development. If the developing 
conceptus is exposed to environmental or infectious agents that 
deplete GSH levels, then orchestrated differentiation events may 
be disrupted, possibly leading to or contributing to birth defects, 
low birth weight, or increased propensity for disease later in life.
Materials and Methods
Materials.  VD3  was  purchased  from  ALEXIS  Corporation 
(Lausen,  Switzerland).  CD11b-PE,  CD71-FITC,  and  PE  and 
FITC isotype controls were from BD Biosciences (San Jose, CA). 
Unless otherwise stated, all other chemicals and reagents were 
purchased from Sigma-Aldrich.
Cell culture. HL-60 cells were purchased from the American 
Type  Culture  Collection  (ATCC)  (Manassas,  VA).  The  cell 
line was cultured in RPMI 1640 with L-glutamine (Mediatech, 
Herndon, VA) with 10% fetal bovine serum and 10 μg/ml gen-
tamicin (Invitrogen, Carlsbad, CA) and incubated at 37°C and 
5% CO2 atmosphere. For all experiments HL-60 cells were 
seeded at 0.3 x 106 cells/ml. Cells were induced to differenti-
ate into granulocyte-like cells through incubation with media 
supplemented with either 1.5% DMSO, or 500 nM ATRA, 
and into monocyte-like cells through incubation with 500 nM 
VD3.
GSH  analysis.  Cell  lysates  were  analyzed  for  intracellular 
GSH  using  an  enzymatic  assay  containing  5,5'-dithio-bis(2-
nitrobenzoic acid), NADPH, and glutathione reductase adapted 
for 96-well plate as described by Baker et al.64 By combining the 
use of small sample volumes with the sensitivity and specificity of 
the GSH assay by enzymatic recycling, this assay provides a rapid 
and sensitive assay for GSH and GSSG in biological samples. 
Protein analysis was performed using the DC Protein Assay kit 
(Bio-Rad, Hercules, CA). The agent 2-vinylpyridine was added 
to cell lysates to determine GSSG levels.
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